Literature DB >> 8366003

Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration.

A J Boujoukos1, G D Martich, E Supinski, A F Suffredini.   

Abstract

Lung cytokine production was examined after the intravenous administration of endotoxin to 23 normal human subjects. Bronchoalveolar lavage (BAL) was performed 7 days before and 1.5 or 5 h after endotoxin (4 ng/kg). Cytokine mRNA was evaluated in cell pellets (> 98% macrophages) by use of reverse transcription and the polymerase chain reaction. Immunoreactivity was measured by enzyme-linked immunosorbent assay of 20- to 40-fold concentrated BAL. Interleukin- (IL) 8 was detected in BAL (4-130 pg/ml) but not in the serum at baseline. Few neutrophils were found in BAL (< 1%) despite this IL-8 gradient. Peak serum IL-8 levels occurred 2 h after endotoxin (3,930 +/- 241 pg/ml), but BAL neutrophils and IL-8 did not increase. Peak serum tumor necrosis factor (TNF) levels occurred 1.5 h after endotoxin (1,844 +/- 210 pg/ml), but TNF was detected in only 1 of 20 BAL samples. TNF and IL-8 mRNA were detected by polymerase chain reaction in > 70% of the BAL samples before endotoxin, whereas IL-1 alpha, IL-1 beta, and IL-6 were detected in < 25% of the BAL samples. After endotoxin, no change was detected in cytokine mRNA expression. Actinomycin D treatment of the BAL did not alter the pattern of cytokine mRNA expression. These data suggest that mechanisms exist to insulate the alveolar space from the stimulatory effects of endotoxin and high circulating levels of cytokines. Additional factors appear to control the chemotactic effects of IL-8 on neutrophils in the air spaces during acute systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8366003     DOI: 10.1152/jappl.1993.74.6.3027

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  18 in total

Review 1.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Changes of inflammation-associated cytokine expressions during early phase of experimental endotoxic shock in macaques.

Authors:  Xiao-Hui Ji; Ke-Yi Sun; Yan-Hong Feng; Guo-Qing Yin
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

3.  Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.

Authors:  B F McAdam; I A Mardini; A Habib; A Burke; J A Lawson; S Kapoor; G A FitzGerald
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

4.  Lipopolysaccharide binding protein in preterm infants.

Authors:  D Behrendt; J Dembinski; A Heep; P Bartmann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

5.  Administration of microparticles from blood of the lipopolysaccharide-treated rats serves to induce pathologic changes of acute respiratory distress syndrome.

Authors:  Hongxia Li; Xiangyu Meng; Xiaoyan Liang; Yue Gao; Shaohua Cai
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-18

6.  Murine responses to endotoxin: another dirty little secret?

Authors:  Robert S Munford
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

7.  Exploring the boundaries of systemic inflammation*.

Authors:  Jason M Elinoff; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

8.  Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators.

Authors:  P D Smith; A F Suffredini; J B Allen; L M Wahl; J E Parrillo; S M Wahl
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

Review 9.  Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.

Authors:  Robert S Parker; Gilles Clermont
Journal:  J R Soc Interface       Date:  2010-02-10       Impact factor: 4.118

10.  Antibodies against CD14 protect primates from endotoxin-induced shock.

Authors:  D J Leturcq; A M Moriarty; G Talbott; R K Winn; T R Martin; R J Ulevitch
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.